liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Multidrug and optimal heart failure therapy prescribing in older general practice populations: a clinical data linkage study
Keele University, Stoke-on-Trent, UK .
Linköping University, Department of Medical and Health Sciences, Division of Nursing Science. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Heart and Medicine Center, Department of Cardiology in Linköping.ORCID iD: 0000-0002-4259-3671
Linköping University, Department of Social and Welfare Studies, Division of Health, Activity and Care. Linköping University, Faculty of Health Sciences.
Keele University, Stoke-on-Trent, UK .
2014 (English)In: BMJ Open, ISSN 2044-6055, Vol. 4, no 1, 003698- p.Article in journal (Refereed) Published
Abstract [en]


To investigate multidrug therapy in the cardiovascular disease (CVD) population and whether it was associated with suboptimal drug prescribing in heart failure (HF).


A population-based cross-sectional clinical data linkage study.


The clinical database populations were registered with three general practices in North Staffordshire that are part of a research network.


3155 patients aged 50 years and over were selected on the basis of a CVD-related prescription and a CVD consultation code applied to their electronic medical record in a 2-year time period. All available diagnostic data were linked to all drugs prescribed data during this time period. Two study groups were: (1) HF and (2) non-HF CVD (reference group).


A standard drug formulary system was used to define four multidrug count categories based on the number of different British National Formulary drug chapters prescribed at the same time.


Optimal HF therapy was defined as the prescribing of ACE inhibitor (ACEi) or a combination of ACEi and β-blocker in the 2-year time window. An additional three specific CVD drug categories that are indicated in HF were also measured.


The HF group, compared with the reference group, had higher non-CVD multidrug therapy (26% with 7 or more counts compared with 14% in the non-HF CVD reference group). For the first-choice optimal drug treatment for HF with ACEi (64%) or ACEi and β-blocker combined therapy (23%), the multidrug-adjusted associations between the HF group and the reference group were OR 3.89; 95% CI 2.8 to 5.5 and 1.99; 1.4 to 2.9, respectively. These estimates were not influenced by adjustment for sociodemographic factors and multidrug counts.


Multidrug therapy prescribing is much higher in the HF group than in a comparable CVD group but did not influence optimal drug prescribing.

Place, publisher, year, edition, pages
BMJ Publishing Group: BMJ Open / BMJ Journals , 2014. Vol. 4, no 1, 003698- p.
Keyword [en]
Heart Failure; Polypharmacy; Comorbidity; Prescriptions
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-106698DOI: 10.1136/bmjopen-2013-003698ISI: 000334311200009PubMedID: 24384895OAI: diva2:717962
Available from: 2014-05-19 Created: 2014-05-19 Last updated: 2014-05-23Bibliographically approved

Open Access in DiVA

fulltext(677 kB)73 downloads
File information
File name FULLTEXT01.pdfFile size 677 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Strömberg, AnnaJaarsma, Tiny
By organisation
Division of Nursing ScienceFaculty of Health SciencesDepartment of Cardiology in LinköpingDivision of Health, Activity and Care
In the same journal
BMJ Open
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 73 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 248 hits
ReferencesLink to record
Permanent link

Direct link